Structure-based drug discovery facilitates future painkiller development
Clin Transl Med
.
2022 Nov;12(11):e1120.
doi: 10.1002/ctm2.1120.
Authors
Yuqing Li
1
,
Teng Li
1
,
Yang Du
2
,
Song Wu
1
Affiliations
1
Department of Experiment & Research, South China Hospital of Shenzhen University, Shenzhen, Guangdong, China.
2
School of Medicine, Kobilka Institute of Innovative Drug Discovery, The Chinese University of Hong Kong, Shenzhen, Guangdong, China.
PMID:
36412509
PMCID:
PMC9680165
DOI:
10.1002/ctm2.1120
No abstract available
MeSH terms
Drug Discovery*
Humans
Opioid-Related Disorders*